LEI 894500NME21ERH0EB816

SYREON Kutató Intézet Korlátolt Felelősségű Társaság

Awards tracked

22

Value

€7.95M

Countries

HU

Download sample CSV

Contract awards & public grants

Cardio-Oncology Multidisciplinary Patient ASsistance Solution → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2026-03-25

€272,500

Detection and Enhanced Food Safety and Security though Efficient Networks for Supply chain Enhancement → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2025-07-16

€398,840

101161333 - VRHEALTHCHAMPIONS - WE ARE HEALTH CHAMPIONS - DISRUPTING THE EUROPEAN HEALTHCARE SYSTEMS WITH VIRTUAL REALITY AND AUGMENTED REALITY APPLIC → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

X - IEEA - Executive Agency for Small and Medium-sized Enterprises · HU · Grant · 2024-10-01

€255,572

THERANOSTICS ECOSYSTEM FOR PERSONALISED CARE → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2024-09-13

€225,000

Support Utilisation of Sustainable and TAilored INnovative methods for HTA → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-11-27

€350,656

Catalysing scientific innovation into food safety action → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-11-20

€98,900

On a Quest for Data-Driven Innovations to fuel Sustainable Food Systems → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-11-07

€225,000

INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-04-21

€518,750

A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-04-21

€518,750

Lomustine with or without reirradiation for first progression of glioblastoma: a pragmatic randomized phase III study → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-04-21

€518,750

ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-04-14

€306,250

A TRUSTworthy speech-based AI monitorING system for the prediction of relapse in individuals with schizophrenia → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2023-04-05

€292,250

Mobilising novel finance models for health promotion and disease prevention → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2022-11-11

€304,813

101081934 - DIGIT-PRE - DIGITAL TOOLS DELIVERING PREVENTION, PREDICTION AND REMOTE CARE THROUGH A RESILIENT EU VALUE NETWORK TO REDUCE HEALTH SYSTEM S → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

X - IEEA - Executive Agency for Small and Medium-sized Enterprises · HU · Grant · 2022-10-01

€359,924

BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2022-05-19

€791,813

TOwards imProved screening for breast, cervical and colorectal cancer in Eastern-Europe: Equitable, Actionable, Sustainable and Trustworthy → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2021-02-04

€275,565

Vaccines and Infectious Diseases in the Ageing PopuLation → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2018-12-10

€255,976

Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement fo → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2018-12-03

€679,163

Healthcare- and pharma-economic models in support of the International Consortium for Personalised Medicine → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2018-11-07

€289,610

Pushing the boundaries of Cost and Outcome analysis of Medical Technologies → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2017-11-21

€331,000

EU-TOPIA: TOWARDS IMPROVED SCREENING FOR BREAST, CERVICAL AND COLORECTAL CANCER IN ALL OF EUROPE → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2015-04-13

€253,250

Sustainable intEgrated care modeLs for multi-morbidity: delivery, FInancing and performancE → SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG

European Commission · HU · Grant · 2015-03-27

€429,238

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.